$92.84+0.92% · 3M
Moving avg
1W-0.89%
1M+0.92%
3M+3.67%
6M-12.31%
YTD-3.98%
1Y-17.62%
3Y-13.59%
5Y-72.94%
52-week range
$79.5230% of range$124.00
Company health
Value1/6
Growth6/6
Profitability2/6
Health5/6
Dividend0/6
Bull vs bear
Strengths
- Analysts see 43% upside to a $133 target
- Analyst consensus is "Buy"
- Revenue compounding 61% a year
- Net cash on the balance sheet
Risks
- Currently unprofitable
Key statistics
Valuation
Market cap
$23.32B
Enterprise value
$10.63B
P/E ratio (TTM)
-15.87x
P/S ratio (TTM)
7.25x
EV/EBITDA
-15.15x
Per share & returns
EPS (TTM)
-$4.93
Dividend yield
0.00%
Beta (1Y)
1.28
30-day change
+0.92%
Trading
Volume (24h)
143.41K
Previous close
$92.74
Shares outstanding
251.20M
About BioNTech SE
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Symbol
BNTX
BioNTech SE is a large-cap healthcare company in the Biotechnology industry. Its shares are listed on NASDAQ (Germany) and trade under the ticker BNTX.
Frequently asked questions
What is BioNTech SE's market cap?
BioNTech SE (BNTX) has a market capitalization of $23.32B.
What sector is BioNTech SE in?
BioNTech SE operates in the Healthcare sector, Biotechnology industry.
What exchange does BNTX trade on?
BNTX trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,221.17+0.07%
$1.15T cap
Johnson & JohnsonJNJ
$261.41+0.21%
$629.97B cap
AbbVie Inc.ABBV
$250.64+0.75%
$442.82B cap
UnitedHealth Group IncorporatedUNH
$403.30-0.56%
$366.25B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.71+1.34%
$332.70B cap
Novartis AGSWX: NOVN
CHF 123.96-0.19%
$290.28B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap